BioCentury | Jun 8, 2015
Company News

Takeda, TWi Pharmaceuticals deal

...TWi and Takeda settled all patent litigation related to TWi’s generic of Takeda’s Dexilant dexlansoprazole for...
BioCentury | Feb 13, 2012
Clinical News

AcipHex rabeprazole regulatory update

...vs. those without PPI exposure. Marketed prescription PPIs in the U.S. include AciPhex from Eisai; Dexilant...
...York, N.Y. Takeda Pharmaceutical Co. Ltd. (Tokyo:4502), Osaka, Japan Product: AcipHex rabeprazole; Dexilant dexlansoprazole (formerly Kapidex...
BioCentury | Dec 5, 2011
Clinical News

Dexilant dexlansoprazole regulatory update

...FDA approved a label change for Dexilant dexlansoprazole to state that no dose adjustment is necessary...
...Plavix clopidogrel. The change was based on results from a study in healthy volunteers showing Dexilant...
...Paris, France) co-market Plavix. Takeda Pharmaceutical Co. Ltd. (Tokyo:4502), Osaka, Japan Product: Dexilant dexlansoprazole (formerly TAK-390MR...
BioCentury | May 23, 2011
Strategy

Takeda's global boost

...for diabetes; and dexlansoprazole, a proton pump inhibitor (PPI) for gastroesophageal reflux disease (GERD). While dexlansoprazole...
...a proton pump inhibitor (PPI) for gastroesophageal reflux disease (GERD). While dexlansoprazole was approved as Dexilant...
...primary endpoint in prostate cancer.I. 1/31/09 - FDA approves Takeda's Dexilant dexlansoprazole delayed-release capsules (formerly Kapidex...
BioCentury | Mar 7, 2011
Clinical News

AciPhex rabeprazole regulatory update

...fractures (see BioCentury, May 31, 2010). Marketed PPIs in the U.S. include AciPhex from Eisai; Dexilant...
...York, N.Y. Takeda Pharmaceutical Co. Ltd. (Tokyo:4502), Osaka, Japan Product: AciPhex rabeprazole; Dexilant dexlansoprazole (formerly Kapidex...
BioCentury | Oct 4, 2010
Clinical News

Dexilant dexlansoprazole regulatory update

...Health Canada approved Dexilant dexlansoprazole delayed-release capsules from Takeda to treat heartburn associated with symptomatic non-erosive...
...U.S. for the indications. Takeda Pharmaceutical Co. Ltd. (Tokyo:4502), Osaka, Japan Product: Dexilant dexlansoprazole (formerly TAK-390MR...
BioCentury | May 31, 2010
Clinical News

AciPhex rabeprazole regulatory update

...or shorter course when prescribing PPIs. Marketed PPIs in the U.S. include AciPhex from Eisai; Dexilant...
...York, N.Y. Takeda Pharmaceutical Co. Ltd. (Tokyo:4502), Osaka, Japan Product: AciPhex rabeprazole; Dexilant dexlansoprazole (formerly Kapidex...
BioCentury | Mar 15, 2010
Company News

Takeda sales and marketing update

...Next month, Takeda will begin marketing Kapidex dexlansoprazole as Dexilant to avoid confusion with Casodex bicalutamide...
...and Kadian. Dexilant will have a new National Drug Code number associated with the product. Dexlansoprazole...
BioCentury | Feb 15, 2010
Clinical News

Prevacid lansoprazole: Phase I started

...75 mg once-daily Plavix clopidogrel. PPIs in the trial will include Prevacid lansoprazole and Kapidex dexlansoprazole...
BioCentury | Nov 2, 2009
Clinical News

Kapidex dexlansoprazole: Post-marketing study data

...A 4-week, double-blind post-marketing trial in 305 patients showed that 30 mg Kapidex delayed-release capsules led...
...percentage of heartburn-free nights vs. placebo (73% vs. 36%, p<0.001). Additionally, 48% and 70% of Kapidex-treated...
...maintenance of healed EE. Takeda Pharmaceutical Co. Ltd. (Tokyo:4502), Osaka, Japan Product: Kapidex dexlansoprazole (formerly TAK-390MR...
Items per page:
1 - 10 of 34